Unknown

Dataset Information

0

Heterologous Boosting With Listeria-Based Recombinant Strains in BCG-Primed Mice Improved Protection Against Pulmonary Mycobacterial Infection.


ABSTRACT: While Baccillus Calmette-Guerin (BCG) is used worldwide, tuberculosis (TB) is still a global concern due to the poor efficacy of BCG. Novel vaccine candidates are therefore urgently required. In this study, two attenuated recombinant Listeria strains, LM?-msv and LI?-msv were constructed by deletion of actA and plcB and expression of a fusion protein consisting of T cell epitopes from four Mycobacterium tuberculosis (Mtb) antigens (Rv2460c, Rv2660c, Rv3875, and Rv3804c). The safety and immunogenicity of the two recombinant strains were evaluated in C57BL/6J mice. After intravenous immunization individually, both recombinant strains entered liver and spleen but eventually were eliminated from these organs after several days. Simultaneously, they induced antigen-specific cell-mediated immunity, indicating that the recombinant Listeria strains were immunogenic and safe in vivo. LM?-msv immunization induced stronger cellular immune responses than LI?-msv immunization, and when boosted with LI?-msv, antigen-specific IFN-? CD8+ T cell responses were notably magnified. Furthermore, we evaluated the protection conferred by the vaccine candidates against mycobacterial infection via challenging the mice with 1 × 107 CFU of BCG. Especially, we tested the feasibility of application of them as heterologous BCG supplement vaccine by immunization of mice with BCG firstly, and boosted with LM?-msv and LI?-msv sequentially before challenging. Combination immune strategy (LM?-msv prime-LI?-msv boost) conferred comparable protection efficacy as BCG alone. More importantly, BCG-vaccinated mice acquired stronger resistance to Mycobacterial challenge when boosted with LM?-msv and LI?-msv sequentially. Our results inferred that heterologous immunization with Listeria-based recombinant strains boosted BCG-primed protection against pulmonary mycobacterial infection.

SUBMITTER: Liu SJ 

PROVIDER: S-EPMC7492678 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Heterologous Boosting With <i>Listeria</i>-Based Recombinant Strains in BCG-Primed Mice Improved Protection Against Pulmonary Mycobacterial Infection.

Liu Si-Jing SJ   Tian Si-Cheng SC   Zhang Yun-Wen YW   Tang Tian T   Zeng Ju-Mei JM   Fan Xiao-Yong XY   Wang Chuan C  

Frontiers in immunology 20200902


While Baccillus Calmette-Guerin (BCG) is used worldwide, tuberculosis (TB) is still a global concern due to the poor efficacy of BCG. Novel vaccine candidates are therefore urgently required. In this study, two attenuated recombinant <i>Listeria</i> strains, LMΔ<i>-msv</i> and LIΔ<i>-msv</i> were constructed by deletion of <i>actA</i> and <i>plcB</i> and expression of a fusion protein consisting of T cell epitopes from four <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>) antigens (<i>Rv2460c, Rv2  ...[more]

Similar Datasets

| S-EPMC4865829 | biostudies-other
| S-EPMC3386939 | biostudies-literature
| S-EPMC5725557 | biostudies-literature
| S-EPMC8601556 | biostudies-literature
| S-EPMC2034536 | biostudies-literature
| S-EPMC4624807 | biostudies-literature
| S-EPMC6277425 | biostudies-literature
| S-EPMC4959472 | biostudies-literature
| S-EPMC5437048 | biostudies-literature
| S-EPMC6538611 | biostudies-literature